drugset
drugset / Trial / NCT03298802

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

NCT03298802 ↗

Phase 3 Terminated 453 enrolled The University of Texas Medical Branch, Galveston
RandomizedParallel-groupTriple-blindPrevention

Summary

Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.

Timeline

Start
2017-11-21
Primary completion
2025-04-22
Completion
2025-04-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrochlorothiazide Unknown 50 mg Oral

Indications

preeclampsia